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Abstract
Background: c-fos may play a role in the pathogenesis of some diseases. The expression and function of c-fos in
viral myocarditis (VMC) have not yet been reported. To study the change and significance of proto-oncogene c-fos
in VMC is the objective of this experiment.
Methods: An animal model of VMC was established via coxsackie virus B3 inoculation. VMC mice were then
treated with a c-fos monoclonal antibody and isoproterenol and the protein and mRNA expression of c-fos were
studied via immunohistochemical analysis and in situ hybridization. Results were simultaneously analyzed for the
significance of c-fos expression in mice with VMC.
Results: Myocardial necrosis and cell infiltration decreased after treatment with c-fos monoclonal antibody
compared to control mice, while myocardial necrosis and cell infiltration were increased after treatment with
isoproterenol. Positive cardiomyocytes with c-Fos expression increased at 3, 5, 7, 9, and 15 days after virus
inoculation in VMC mice compared to control mice, while returning to almost normal levels at 35 days. The
expression level of c-fos mRNA at 3 and 7 days after virus inoculation in VMC mice was also higher than that of
control mice.
Conclusions: c-fos expression in the cardiomyocytes of VMC mice is significantly increased, c-fos plays an
important role in myocardial lesions. The apparent increase in expression of c-fos is likely to be involved in the
pathogenesis of VMC.
Background
The proto-oncogene c-fos participates in a variety of
physiological process including cell growth, differentia-
tion, transformation, signal transduction, and plasticity
of the nervous system [1]. The expression of c-fos is
known to be increased in particular diseases and patho-
physiological processes, indicating that it may play a
role in the pathogenesis of some diseases. The expres-
sion and function of c-fos in viral myocarditis (VMC)
have not yet been reported. Therefore, our experiments
were focused on the study of the expression of c-fos in
VMC by ways of immunohistochemical analysis and
in situ hybridization. Simultaneously, we investigated
the significance of c-fos in VMC via medicine treatment
with c-fos monoclonal antibody or isoproterenol.
Materials and Methods
Animals
BALB/c mice, male, 4-6 weeks old, 16-20 grams.
Main reagents
c-fos monoclonal antibody, isoproterenol, normal goat
serum, rabbit anti-c-fos oncogene protein, Biotinylated
goat anti rabbit IgG, Streptavidin Biotin-peroxidase
Complex (SABC), antigen restoration solution, pepsin,
c-fos oligonucleotide probe, Occlusive solution, and rab-
bit anti digoxin were purchased from Boster Biological
Technology Ltd.(Wuhan, China), Sigma Chemical Co.
(Sigma, St.Louis, MO) and Biocompare Co.(South San
Francisco, CA).
Establishing of animal model (VMC)
130 mice were divided into two groups: the experimen-
tal group (120 mice) and the control group (10 mice).
Each mouse of the experimental group was inoculated
with coxsackie virus B3 (CVB3), while control mice were
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mental mice were sacrificed at day (D) 3, 5, 7, 9, 15, and
35 after inoculation (Groups D3,D 5,D 7,D 9,D 15, and
D35). 120 mice were included in the experiment group,
but some mice died, some mice lost, some mice bit each
other lead to death and also because of some other rea-
sons, we only got 60 specimens at last. Dead mice num-
ber of every sub-group: 5 in GroupD3, 6 in Group D5,8
in Group D7,7i nG r o u pD 9,8i nG r o u pD 15 and 7 in
Group D35.
Medicine treatment
Another one hundred and twenty mice were divided
into three groups of 40 mice each (GroupE1, E2, and E3).
Each group of mice was inoculated with 0.1 mL of cox-
sackie virus B3 (CVB3). Each mice of Group E1 was then
inoculated with 5 μg of c-fos monoclonal antibody via
intraperitoneal injection every day for 3 days. Group E2
mice were inoculated with 1 μg of isoproterenol every
day for three days. Group E3 mice were inoculated with
0.1 mL of normal saline for three days. Each group was
divided into two subgroups (20 mice/subgroup), in
which one subgroup was sacrificed on day 7, and the
other was sacrificed at day 15.
Specimen collection
Serum was isolated from blood samples and refrigerated
for further use. Each heart specimen was divided into
two portions, in which one portion was fixed with 10%
methanol. Paraffin-embedded tissue samples were cut
into 5 μm sections and stained with hematoxyline/eosin
according to standard procedures and observed under a
light microscope (Olympus). The remaining portion of
the sample was preserved with glutaric dialdehyde to be
used for electron microscopy.
Immunohistochemical and in situ analysis of the c-fos
oncogone
Heart specimens were fixed in 10% methanol for 24
hours and paraffin-embedded tissue samples were cut
into 5 μm sections. 5 sections were used in every exam-
ple, sections were mounted on 3-aminopropyltriethoxy-
silane (APES) treated slides followed by incubation at
56°C for 1-2 hours, followed by 37°C incubation for
3 days.
Immunohistochemical analysis of c-Fos oncogene pro-
tein: After standard deparaffination and rehydration,
specimens were exposed to xylol for 10 minutes, 100%
alcohol for 5 minutes, 96% alcohol for 5 minutes, and
70% alcohol for 3 minutes. Endogenous peroxidase
activity was quenched by exposure to 3% hydrogen per-
oxide for 10 minutes. The antigen was restored by
citrate-buffered (pH 6.0). Normal goat serum was added
for 10 minutes at room temperature, c-Fos antibody was
added at 37°C for 1.5 hours followed by washing with
phosphate-buffered saline (PBS). Biotinylated goat anti-
rabbit IgG was added for 20 minutes at 37°C followed
by a PBS wash. Streptavidin Biotin-peroxidase Complex
(SABC) was added for 20 minutes at 37°C and then
rinsed with PBS. The color was then developed with dia-
minobenzidine (DAB) at room temperature, and rinsed
with distilled water after the reactive time was con-
trolled under the light microscope. Sections were
restained with hematoxylin, and incubated at 37°C and
sealed with neutral gum. Slides were observed under the
light microscope.
In situ hybridization of the c-fos oncogene: Formalin-
fixed paraffin-embedded heart specimens were deparaffi-
nized with xylene and rehydrated with graded ethanol.
T h ee n d o g e n o u sp e r o x i d a s ea c t i v i t yw a sq u e n c h e db y
exposure to 3% hydrogen peroxide for 10 minutes. Sam-
ples were then incubated with pepsin (diluted with 3%
citric acid) at 37°C for 20 minutes and rinsed with 0.5
M PBS and distilled water.
The Digoxin-labeled probe was added to the sections
and sections were then covered with coverslips and
incubated overnight at 37°C. After the coverslips were
disclosed, the sections were rinsed with 2×SSC (17.6 g
sodium chloride and 8.8 g sodium citrate in 1000 mL of
distilled water), and 0.2 × SSC (1:10 dilution from
2×SSC). Rabbit anti-Digoxin was added to the sections
for 60 minutes at 37°C, then rinsed with 0.5 M PBS.
Biotinylated goat anti-rabbit IgG was added for 30 min-
utes at 37°C, then rinsed with 0.5 M PBS. SABC was
added for 30 minutes at 37°C, then rinsed with 0.5 M
PBS. Sections were colored with DAB, and the reactive
time was controlled under the light microscope. Sec-
tions were restained with hematoxylin and sealed with
neutral gum and was observed under the light
microscope.
Determination of results
A blue cell nucleus indicated a normal cardiomyocyte,
while a brown-yellow nucleus indicated positive expres-
sion in the cardiomyocyte of the c-Fos oncogene pro-
tein. Brown-yellow particles in the cytoplasm indicated
positive expression of c-fos oncogene mRNA. The num-
ber of positive cell nucleus (or cytoplasm) of five high-
power fields were calculated under light microscope,
average value was calculated.
Histopathological Examination
One section of the heart specimen was fixed in 10% for-
malin, embedded in paraffin, stained with hematoxylin
and eosin, and then observed by microscopy at 200 ×
magnification. According to the myocardial lesions,
including cell necrosis and cellular infiltration, each spe-
cimen was given a score by two observers who were
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scores were evaluated as follows: 0, no lesions; 1, lesions
involving <25% of the myocardium; 2, lesions involving
25% to 50% of the myocardium; 3, lesions involving 50%
to 75% of the myocardium; and 4, lesions involving
>75% of the myocardium.
Statistics
All data were expressed as mean ± standard deviation
(SD). A t-test or variance analysis was used to compare
data between groups. A level of p < 0.05 was considered
to be statistically significant.
Results
Establishing an animal model of VMC(Evidence of VMC)
Signs of VMC were apparent in the experimental groups
at 3 days after virus inoculation including coat ruffling,
weakness, and irritability. On day 3, a few scattered
small foci of myocyte necrosis were noted. Myocardial
necrosis and cell infiltration were extensive on day 7,
with necrotic areas appearing more prominent. There
were many lymphocytes and macrophages in and
around the necrotic foci. Infiltration of the inflammatory
cells and necrotic areas were decreased, and necrotic
myocardium gradually changed to fibrosis and calcifica-
tion on day 15, at which time fibrosis was noted in the
interstitium. There were no necrotic lesions or signs of
cell infiltration in the hearts of uninfected control mice.
Expression of c-Fos oncogene protein in VMC mice
A few c-Fos oncogene protein positive cardiomyocyte
nuclei were seen in mice of the control group. Positive
expression of c-Fos protein increased significantly at 3
days after virus inoculation in VMC mice. The propor-
tion of positive cardiomyocyte nucleus and total cardio-
myocyte nucleus also increased apparently with the
advance of the disease. The peak level was at 7-9 days
after virus inoculation (Table 1, Figures 1 and 2). Posi-
tive c-Fos protein expression in cardiomyocyte nuclei
was almost normal at 35 days after virus inoculation.
Expression change of c-fos oncogene mRNA
A few c-fos mRNA expression positive cardiomyocytes
were observed in mice of the control group. Positive c-
fos mRNA expression in cardiomyocytes increased at 3
and 7 days after virus inoculation (Table 2, Figure 3).
The results of Medicine treatment
Infiltration of the inflammatory cells and necrotic areas
were decreased in the c-fos monoclonal antibody treat-
ment group (Group E1) compared with the control nor-
mal saline treatment group (Group E3)a t7a n d1 5d a y s
after virus inoculation, infiltration of the inflammatory
cells and necrotic areas were increased in the isoprotere-
nol treatment group (Group E2)( T a b l e3 ,F i g u r e s4 ,5
and 6).
Discussion
A broad range of extracellular signals trigger cells to
adapt and grow according to their environment. Proto-
oncogenes play an important role in signal transduction,
a process that converts external stimuli into intracellular
signals that guide cellular function. Within the past 10-
15 years of oncogene research, the identification of
Table 1 The expression change of c-Fos oncogene
protein in VMC mice
Group Number PCN/HPF PCN/TCN(%)
D3 7 43.86 ± 14.18
Δ 9.52 ± 2.80
Δ
D5 8 66.63 ± 21.71
Δ 16.73 ± 5.76
Δ
D7 8 109.79 ± 29.25
Δ 27.92 ± 7.87
Δ
D9 8 75.19 ± 20.67
Δ 18.26 ± 4.71
Δ
D15 10 56.64 ± 21.06
Δ 13.62 ± 5.08
Δ
D35 7 9.37 ± 4.07 2.37 ± 1.20
Control 10 8.25 ± 2.44 2.03 ± 0.60
PCN: Positive cardiomyocyte nucleus; TCN: Total cardiomyocyte nucleus.
Δ: p < 0.01 compared with control group.
Figure 1 The proportion change of positive cardiomyocyte
nucleus of c-Fos protein in VMC mice.
Figure 2 The expression of c-Fos protein in cardiomyocytes of
VMC mice at 9 days after virus inoculation (400×).
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duction pathways has been a major discovery in the
field. These and other recent findings suggest that sev-
eral new areas are emerging as important topics for
future investigation in molecular oncogenesis.
Although the study of oncogenes has provided some
useful insights into cancer mechanisms, the most benefi-
cial aspect has been the delineation of the growth factor
response pathway and molecular characterization of var-
ious important cellular processes. The nuclear proto-
oncogenes c-fos and c-jun have been particularly useful
in this regard. These studies have provided important
information about gene regulation in response to growth
factors, regulation of immediate early genes, and the
function and interaction of transcription factors.
The Fos oncogene was discovered as the cellular
homologue of three distinct tumor viruses derived from
mice and chicken [2]. Both the normal and viral Fos
transforming proteins complex with a 39-KD protein
[3]. The genes c-fos and c-myc were the first to be iden-
tified as immediate early genes after detailed analysis of
their mRNA expression patterns. The transient induc-
tion of c-fos expression is mediated by multiple trans-
acting factors. The c-fos mRNA and its 55-kDa nuclear
phosphoprotein (Fos) are rapidly, but transiently,
induced by both growth factors and differentiating
agents [4].
c-Fos may play a role as a potent inducer of apoptosis
in pro-B cells and Ig class-switching B cells. c-Fos
induced apoptosis is further supported by findings that
induction of c-Fos expression is an early event in many
cases of mammalian apoptosis [5,6]. Moreover, reduc-
tion of c-Fos activity by antisense oligonucleotides is
able to prevent growth factor-deprived lymphoid cells
from undergoing apoptosis. These results suggest that c-
Fos may indeed have a protective function, including
DNA repair, against harmful consequences of agents [7].
The proto-oncogene c-fos encodes a nuclear phospho-
protein (c-Fos). c-Fos, in a complex with products of
another proto-oncogene, c-jun (AP-1), regulates the
expression of AP-1 binding genes at the transcriptional
level [8]. Overexpression of c-fos may play roles in some
diseases, such as Alzheimer’s disease, arthritis, myocar-
dial stunning, neonatal hypoxia-ischemia, cardiac ische-
mia-reperfusion, and heart failure [9-18].
The c-fos protein expression induced by arthritis was
found in rats, and pathological pain following arthritis
activated pain sensitive neurons and evoked c-fos
Table 2 The expression change of c-fos oncogene mRNA
in VMC mice
Group Number NPC/HPF NPC/NTC(%)
D3 7 28.22 ± 10.31
Δ 6.79 ± 2.34
Δ
D7 8 52.24 ± 16.69
Δ 12.85 ± 4.73
Δ
Control 10 6.76 ± 2.35 1.64 ± 0.56
NPC: number of positive cardiomyocyte; NTC: number of total cardiomyocyte.
Δ: p < 0.01 compared with control group.
Figure 3 The expression of c-fos mRNA in cardiomyocytes of
VMC mice at 7 days after virus inoculation (200×).
Figure 4 Myocardial lesions in mice of the c-fos monoclonal
antibody treatment group (200×).
Figure 5 Myocardial lesions in mice of the isoproterenol
treatment group (200×).
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the central nervous system is induced by some patholo-
gical stimulation. c-fos mRNA was overexpressed in the
hippocampal neurons of the patients with Alzheimer’s
disease [9]. In rat models of myocardial stunning (MS),
the expression of Fos protein increased apparently.
Therefore, Fos may play a role in MS since it has close
relation to injury repair of the molecule [10]. Cerebral
hypoxia and/or ischemia also produce hyperexpression
of specific genes(c-fos, c-jun) which may be involved in
the mechanisms of excitotoxic neuronal death. Overall,
Fos expression is mainly associated with cellular damage
and subsequent death following hypoxic-ischemic injury.
Gonzalez CA et al. [11] assayed the Fos protein using
immunohistochemical staining, and showed that the
administration of naloxone methiodide or naloxone to
morphine-dependent rats induced a marked Fos immu-
noreactivity within cardiomyocyte nuclei. Western blot
analysis revealed a peak expression of c-fos in the right
and left ventricles after naloxone methiodide withdrawal.
Fos expression was increased after naloxone administra-
tion to morphine-dependent rats. These results sug-
gested that the activation of c-fos expression observed
during morphine withdrawal in the heart is due to
intrinsic mechanisms outside of the central nervous sys-
tem (CNS). To analyze differential gene expression after
myocardial ischemia-reperfusion, Nelson assayed
humans for the related immediate early genes c-fos and
c-jun with in situ hybridization and also performed test-
ing on lamb myocardium subjected to cardiopulmonary
bypass with myocardial ischemia. The results showed
that c-fos and c-jun were induced in ischemia-reperfu-
sion myocardium at endcardiopulmonary bypass.
Expression patterns of c-fos and c-jun by in situ hybridi-
zation were markedly different; myocardial c-fos expres-
sion was diffuse and homogeneous, whereas c-jun
expression was patchy with areas of intense focal locali-
zation [12].
Since TNF-a and other cytokines increase apparently
in VMC [19-21], Isoproterenol, TNF-a and other cyto-
kines induce expression of c-fos and the c-jun oncogene
[22-25], we deduced that abnormal expression of c-Fos
c a nb eo b s e r v e di nV M C .I no u re x p e r i m e n t ,p r o t e i n
expression of c-Fos increased apparently compared with
control mice at 3 days after virus inoculation, and
increased further with the advance of disease. Expres-
sion peaked at 7-9 days, decreased gradually, and then
became almost normal at 35 days after virus inoculation.
The expression of c-fos mRNA in VMC mice was also
higher than that of the control group at 3 days and 7
days after virus inoculation. Results indicated that the
expression of c-fos increased in cardiomyocyte of VMC
mice, and that c-Fos can compose AP-1 with c-jun gene
products.
TNF-a also stimulated collagenase gene transcription.
This stimulation is mediated by an element of the gene
that is responsive to the transcription factor AP-1, and
then the product of collagenase increase. Collagenase
plays an important role in the course of tissue inflam-
mation [26,27]. Therefore, we deduced that abnormal
expression of c-fos may play a role in an inflammatory
disease, specifically, VMC. In addition, c-fos can also
regulate the transcription of apoptosis-related genes and
thereby regulate cardiomyocyte apoptosis indirectly [28]
in VMC. In our experiment, infiltration of the
inflammatory cells and necrotic areas were decreased
after c-fos was neutralized by c-fos monoclonal antibody
treatment compared with the control normal saline
treatment group. Infiltration of the inflammatory cells
and necrotic areas were increased after increase of c-fos
Figure 6 Myocardial lesions in mice of the normal saline
treatment group (200×).
Table 3 Effect of medicine treatment on myocardial lesions of VMC mice
Group 7d 15d
Number I N Number I N
E1 13 1.21 ± 0.53
Δ 0.97 ± 0.43* 12 0.94 ± 0.52* 0.72 ± 0.38*
E2 7 2.23 ± 0.91* 1.96 ± 0.79
Δ 9 1.88 ± 0.81
Δ 1.67 ± 0.70
Δ
E3 8 1.85 ± 0.64 1.32 ± 0.55 10 1.31 ± 0.63 1.08 ± 0.52
I: Infiltration of the inflammatory cells; N: necrotic areas.
*: p < 0.05 compared with Group E3;.
Δ: p < 0.01 compared with Group E3.
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that c-fos plays an important role in myocardial lesions
and is likely to be involved in the pathogenesis of VMC.
Conclusions
c-fos expression in the cardiomyocytes of VMC mice is
significantly increased, c-fos plays an important role in
myocardial lesions. The apparent increase in expression
of c-fos is likely to be involved in the pathogenesis of
VMC.
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